Cover Image
Market Research Report
Product code
1028004

North America Eubiotics Market Forecast 2021-2028

Published: | Inkwood Research | 169 Pages | Delivery time: 2-3 business days

Price

Back to Top
North America Eubiotics Market Forecast 2021-2028
Published: September 14, 2021
Inkwood Research
Content info: 169 Pages
Delivery time: 2-3 business days
  • ALL
  • Description
  • Table of Contents
Description

KEY FINDINGS

The North America eubiotics market is anticipated to develop with a CAGR of 6.83% across the forecast period of 2021 to 2028. The regional market's growth is primarily attributed to the surging consumption of meat, the rising concerns associated with the quality of meat as well as its health influences, and stringent regulations surrounding the usage of antibiotics.

MARKET INSIGHTS

The North America eubiotics market growth evaluation encompasses the study of Canada and the United States. In 2019, the consumption of beef, per capita, equated to nearly 27.4 kilograms in Canada. Besides, chicken was the most consumed meat in the country in 2019.

On the other hand, the Canadian Pork Council, along with the dairy, meat, and poultry industries, are predominantly focused on the protection of their farms and businesses. They also concentrate on safeguarding the livelihoods of the Canadian population from the threat of significant, multi-species, and border-closing infectious ailments.

While animal agriculture is highly essential for food production in Canada, it is also vital for the country's development. Furthermore, the growing reservations regarding zoonotic diseases, food safety, animal health, and antimicrobial stewardship continue to augment the demand for eubiotics in Canada. As a result, these factors are set to propel the market growth in North America during the forecasted years.

COMPETITIVE INSIGHTS

Some of the leading firms operating in the market are: DuPont de Nemours Inc, Cargill Inc, Archer Daniels Midland Co (ADM), Novus International Inc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 40329

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. RISING AWARENESS AND CONCERNS ABOUT ANIMAL HEALTH
    • 3.1.2. INCREASED MEAT CONSUMPTION
    • 3.1.3. INCREASED DEMAND FOR MANUFACTURED FEEDS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. UNAWARENESS ABOUT EUBIOTICS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON EUBIOTICS MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE

5. MARKET BY PRODUCT

  • 5.1. PROBIOTICS
  • 5.2. ORGANIC ACID
  • 5.3. PREBIOTICS
  • 5.4. ESSENTIAL OILS

6. MARKET BY FORM

  • 6.1. SOLID FORM/DRY FORM
  • 6.2. LIQUID

7. MARKET BY PACKAGING

  • 7.1. BULK PACKAGING
  • 7.2. STAND-UP POUCHES/PORTION CONTROL

8. MARKET BY LIVESTOCK

  • 8.1. SWINE
  • 8.2. POULTRY
  • 8.3. RUMINANTS
  • 8.4. AQUACULTURE
  • 8.5. OTHER LIVESTOCK

9. MARKET BY APPLICATION

  • 9.1. GUT HEALTH
  • 9.2. IMMUNITY
  • 9.3. YIELD MANAGEMENT
  • 9.4. OTHER APPLICATIONS

10. MARKET BY END-USER

  • 10.1. ANIMALS
  • 10.2. HUMANS

11. GEOGRAPHICAL ANALYSIS

  • 11.1. NORTH AMERICA
    • 11.1.1. MARKET SIZE & ESTIMATES
    • 11.1.2. KEY DRIVERS
    • 11.1.3. KEY CHALLENGES
    • 11.1.4. KEY PLAYERS
    • 11.1.5. COUNTRY ANALYSIS
      • 11.1.5.1. UNITED STATES
      • 11.1.5.2. CANADA

12. COMPETITIVE LANDSCAPE

  • 12.1. KEY STRATEGIC DEVELOPMENTS
    • 12.1.1. MERGERS & ACQUISITIONS
    • 12.1.2. PRODUCT LAUNCHES
    • 12.1.3. PARTNERSHIPS & AGREEMENTS
    • 12.1.4. BUSINESS EXPANSIONS
  • 12.2. COMPANY PROFILES
    • 12.2.1. ANPARIO PLC
    • 12.2.2. ARCHER DANIELS MIDLAND CO (ADM)
    • 12.2.3. BASF SE
    • 12.2.4. BEHN MEYER GROUP
    • 12.2.5. BENEO GMBH
    • 12.2.6. CARGILL INC
    • 12.2.7. CHR HANSEN HOLDING A/S
    • 12.2.8. DUPONT DE NEMOURS INC
    • 12.2.9. KEMIN INDUSTRIES INC
    • 12.2.10. KONINKLIJKE DSM NV
    • 12.2.11. LALLEMAND INC
    • 12.2.12. LESAFFRE
    • 12.2.13. NEOSPARK DRUGS AND CHEMICALS PRIVATE LIMITED
    • 12.2.14. NOVUS INTERNATIONAL INC
    • 12.2.15. YARA INTERNATIONAL ASA

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - EUBIOTICS
  • TABLE 2: MAJOR LIVESTOCK DISEASES IN THE WORLD
  • TABLE 3: COUNTRIES WITH THE HIGHEST ANNUAL MEAT CONSUMPTION
  • TABLE 4: NORTH AMERICA EUBIOTICS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: NORTH AMERICA EUBIOTICS MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: NORTH AMERICA EUBIOTICS MARKET, BY FORM, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: NORTH AMERICA EUBIOTICS MARKET, BY FORM, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: NORTH AMERICA EUBIOTICS MARKET, BY PACKAGING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: NORTH AMERICA EUBIOTICS MARKET, BY PACKAGING, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: NORTH AMERICA EUBIOTICS MARKET, BY LIVESTOCK, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: NORTH AMERICA EUBIOTICS MARKET, BY LIVESTOCK, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: NORTH AMERICA EUBIOTICS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 13: NORTH AMERICA EUBIOTICS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 14: NORTH AMERICA EUBIOTICS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 15: NORTH AMERICA EUBIOTICS MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 16: NORTH AMERICA EUBIOTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 17: NORTH AMERICA EUBIOTICS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 18: KEY PLAYERS IN NORTH AMERICA EUBIOTICS MARKET
  • TABLE 19: LIST OF MERGERS & ACQUISITIONS
  • TABLE 20: LIST OF PRODUCT LAUNCHES
  • TABLE 21: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 22: LIST OF BUSINESS EXPANSIONS

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: NORTH AMERICA EUBIOTICS MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2020
  • FIGURE 6: NORTH AMERICA EUBIOTICS MARKET, BY PROBIOTICS, 2021-2028 (IN $ MILLION)
  • FIGURE 7: NORTH AMERICA EUBIOTICS MARKET, BY ORGANIC ACID, 2021-2028 (IN $ MILLION)
  • FIGURE 8: NORTH AMERICA EUBIOTICS MARKET, BY PREBIOTICS, 2021-2028 (IN $ MILLION)
  • FIGURE 9: NORTH AMERICA EUBIOTICS MARKET, BY ESSENTIAL OILS, 2021-2028 (IN $ MILLION)
  • FIGURE 10: NORTH AMERICA EUBIOTICS MARKET, GROWTH POTENTIAL, BY FORM, IN 2020
  • FIGURE 11: NORTH AMERICA EUBIOTICS MARKET, BY SOLID FORM/DRY FORM, 2021-2028 (IN $ MILLION)
  • FIGURE 12: NORTH AMERICA EUBIOTICS MARKET, BY LIQUID, 2021-2028 (IN $ MILLION)
  • FIGURE 13: NORTH AMERICA EUBIOTICS MARKET, GROWTH POTENTIAL, BY PACKAGING, IN 2020
  • FIGURE 14: NORTH AMERICA EUBIOTICS MARKET, BY BULK PACKAGING, 2021-2028 (IN $ MILLION)
  • FIGURE 15: NORTH AMERICA EUBIOTICS MARKET, BY STAND-UP POUCHES/PORTION CONTROL, 2021-2028 (IN $ MILLION)
  • FIGURE 16: NORTH AMERICA EUBIOTICS MARKET, GROWTH POTENTIAL, BY LIVESTOCK, IN 2020
  • FIGURE 17: NORTH AMERICA EUBIOTICS MARKET, BY SWINE, 2021-2028 (IN $ MILLION)
  • FIGURE 18: NORTH AMERICA EUBIOTICS MARKET, BY POULTRY, 2021-2028 (IN $ MILLION)
  • FIGURE 19: NORTH AMERICA EUBIOTICS MARKET, BY RUMINANTS, 2021-2028 (IN $ MILLION)
  • FIGURE 20: NORTH AMERICA EUBIOTICS MARKET, BY AQUACULTURE, 2021-2028 (IN $ MILLION)
  • FIGURE 21: NORTH AMERICA EUBIOTICS MARKET, BY OTHER LIVESTOCK, 2021-2028 (IN $ MILLION)
  • FIGURE 22: NORTH AMERICA EUBIOTICS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020
  • FIGURE 23: NORTH AMERICA EUBIOTICS MARKET, BY GUT HEALTH, 2021-2028 (IN $ MILLION)
  • FIGURE 24: NORTH AMERICA EUBIOTICS MARKET, BY IMMUNITY, 2021-2028 (IN $ MILLION)
  • FIGURE 25: NORTH AMERICA EUBIOTICS MARKET, BY YIELD MANAGEMENT, 2021-2028 (IN $ MILLION)
  • FIGURE 26: NORTH AMERICA EUBIOTICS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 27: NORTH AMERICA EUBIOTICS MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020
  • FIGURE 28: NORTH AMERICA EUBIOTICS MARKET, BY ANIMALS, 2021-2028 (IN $ MILLION)
  • FIGURE 29: NORTH AMERICA EUBIOTICS MARKET, BY HUMANS, 2021-2028 (IN $ MILLION)
  • FIGURE 30: NORTH AMERICA EUBIOTICS MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 31: UNITED STATES EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 32: CANADA EUBIOTICS MARKET, 2021-2028 (IN $ MILLION)